Literature DB >> 21298775

Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies.

Prashant Warang1, Maya Gupta, Prabhakar Kedar, Kanjaksha Ghosh, Roshan Colah.   

Abstract

BACKGROUND: Among the red cell membrane disorders, hereditary spherocytosis (HS) is one of the most common causes of inherited hemolytic anemia. The aim of this study was to compare the flow-cytometric approach for screening of red cell membrane disorders based on osmotic fragility with the eosin-5-maleimide (E5'M) dye test. A group of β-thalassemia heterozygotes were also studied.
METHODS: A red cell suspension was spiked with deionized water during acquisition and the count of residual red cells measured sequentially in real-time using flow cytometry. Fluorescence intensity of red cells stained with eosin-5-maleimide was also measured.
RESULTS: The hereditary spherocytosis (HS) group showed significantly decreased percentage residual red cells (9.31% ± 3.75%) (P = 0.0091) whereas the β-thalassemia group showed a significant increase (93.56% ± 12.98%) (P = 0.0008) compared to the normal control group (46.26% ± 11.33%). The cut off value of the flow cytometric osmotic fragility (FCM OF) test for red cell membrane disorders was 23.59% giving a sensitivity of 100% and specificity of 98%.
CONCLUSIONS: The advantages of the FCM OF test are that it is quantitative, time effective and requires only deionized water for the measurement of osmotic fragility. It could be an effective first line screening approach for red cell membrane disorders in hematology laboratories where a flow cytometer is available.
Copyright © 2011 International Clinical Cytometry Society.

Entities:  

Mesh:

Year:  2011        PMID: 21298775     DOI: 10.1002/cyto.b.20583

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  5 in total

Review 1.  A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.

Authors:  Robert D Christensen; Hassan M Yaish; Patrick G Gallagher
Journal:  Pediatrics       Date:  2015-06       Impact factor: 7.124

2.  Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.

Authors:  Prabhakar S Kedar; Hideo Harigae; Etsuro Ito; Hideki Muramatsu; Seiji Kojima; Yusuke Okuno; Tohru Fujiwara; Rashmi Dongerdiye; Prashant P Warang; Manisha R Madkaikar
Journal:  Int J Hematol       Date:  2019-08-10       Impact factor: 2.490

3.  Flow Cytometric Eosin-5'-Maleimide Test is a Sensitive Screen for Hereditary Spherocytosis.

Authors:  Preethi S Chari; Sujay Prasad
Journal:  Indian J Hematol Blood Transfus       Date:  2017-12-06       Impact factor: 0.900

4.  Plasmodium vivax infection compromises reticulocyte stability.

Authors:  Martha A Clark; Usheer Kanjee; Gabriel W Rangel; Laura Chery; Anjali Mascarenhas; Edwin Gomes; Pradipsinh K Rathod; Carlo Brugnara; Marcelo U Ferreira; Manoj T Duraisingh
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

5.  The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.

Authors:  Sari Peretz; Leonid Livshits; Etheresia Pretorius; Asya Makhro; Anna Bogdanova; Max Gassmann; Ariel Koren; Carina Levin
Journal:  Front Physiol       Date:  2022-08-29       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.